Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group

Bibliographic Details
Title: Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group
Authors: Fountzilas, Elena, Koliou, Georgia-Angeliki, Vozikis, Athanassios, Rapti, Vassiliki, Nikolakopoulos, Achilleas, Boutis, Anastasios, Christopoulou, Athina, Kontogiorgos, Ioannis, Karageorgopoulou, Sofia, Lalla, Efthalia, Tryfonopoulos, Dimitrios, Boukovinas, Ioannis, Rapti, Cleopatra, Nikolaidi, Adamantia, Karteri, Sofia, Moirogiorgou, Evangelia, Binas, Ioannis, Mauri, Davide, Aravantinos, Gerasimos, Zagouri, Flora, Saridaki, Zacharenia, Psyrri, Amanda, Bafaloukos, Dimitrios, Koumarianou, Anna, Res, Eleni, Linardou, Helena, Mountzios, Giannis, Razis, Evangelia, Fountzilas, George, Koumakis, Georgios
Source: In ESMO Open 2020 5(4)
Database: ScienceDirect
More Details
ISSN:20597029
DOI:10.1136/esmoopen-2020-000774
Published in:ESMO Open
Language:English